Skip to main content

Table 3 Signs and symptoms of diarrhea by STIDAT dimension

From: Development and validation of a patient-reported questionnaire assessing systemic therapy induced diarrhea in oncology patients

Dimension

All patients

No diarrhea

All patients with diarrhea

Mild diarrhea

Moderate diarrhea

Severe diarrhea

Patient’s perception of having diarrhea

 

STIDAT

  

Diarrhea

54/113 (47.8%)

0/56 (0%)

54/57 (94.7%)

18/21 (85.7%)

30/30 (100%)

6/6 (100%)

  

No diarrhea

59/113 (52.2%)

56/56 (100%)

3/57 (5.3%)

3/21 (14.3%)

0/30 (0%)

0/6 (0%)

 

Diary

  

Diarrhea

47/113 (41.6%)

0/56 (0%)

47/57 (82.5%)

16/21 (76.2%)

26/30 (86.7%)

5/6 (83.3%)

  

No diarrhea

44/113 (38.9%)

39/56 (69.6%)

5/57 (8.8%)

3/21 (14.3%)

2/30 (6.7%)

0/6 (0%)

  

Unevaluable

22/113 (19.5%)

17/56 (30.4%)

5/57 (8.78%)

2/21 (9.5%)

2/30 (6.6%)

1/6 (16.7%)

Mean number of bowel movements (SD)

 

STIDAT

1.90 (1.31)

1.55 (0.91)

2.23 (1.55)

1.60 (0.89)

2.18 (1.43)

4.58 (1.80)

 

Diary

1.90 (1.34)

1.78 (1.18)

1.99 (1.50)

1.72 (1.42)

1.89 (1.30)

3.37 (2.13)

Mean number of diarrheal episodes (SD)

 

STIDAT

0.92 (1.46)

0.003 (0.019)

1.90 (1.60)

1.11 (0.82)

1.83 (1.22)

4.58 (2.20)

 

Diary

0.73 (1.30)

0.11 (0.44)

1.38 (1.56)

0.99 (1)

1.22 (1.23)

3.41 (3.40)

Presence of urgency

 

STIDAT

  

Present

58/113 (51.3%)

14/56 (25%)

44/57 (77.2%)

16/21 (76.2%)

23/30 (76.7%)

5/6 (83.3%)

  

Absent

55/113(48.7%)

42/56 (75%)

13/57 (22.8%)

5/21 (23.8%)

7/30 (23.3%)

1/6 (16.7%)

 

Diary

  

Present

64/113 (57.1%)

17/56 (30.4%)

46/57 (80.7%)

14/21 (66.7%)

26/30 (86.7%)

6/6 (100%)

  

Absent

48/113 (42.9%)

39/56 (69.6%)

9/57 (15.8%)

5/21 (23.8%)

4/30 (13.3%)

0/6 (100%)

  

Unevaluable

1/113 (0%)

0/56 (0%)

2/57 (3.6%)

2/21 (9.5%)

0/30 (0%)

0/6 (100%)

Presence of abdominal discomfort

 

STIDAT

  

Present

52/113 (46.0%)

18/56 (32.1%)

34/57 (59.6%)

9/21 (42.9%)

19/30 (63.3%)

6/6 (100%)

  

Absent

61/113 (55.0%)

38/56 (67.9%)

23/57 (40.4%)

12/21 (57.1%)

11/30 (36.7%)

0/6 (100%)

 

Diary

  

Present

63/113 (55.8%)

22/56 (39.3%)

41/57 (71.9%)

11/21 (52.4%)

24/30 (80%)

6/6 (100%)

  

Absent

49/113 (43.4%)

34/56 (60.7%)

15/57 (26.3%)

9/21 (42.9%)

6/30 (20%)

0/6 (0%)

  

Unevaluable

1/113 (0.8%)

0/56 (0%)

1/57 (1.8%)

1/21 (4.7%)

0/30 (0%)

0/6 (0%)

Presence of abdominal spasms

 

STIDAT

  

Present

39/113 (34.2%)

11/56 (19.6%)

28/57 (49.1%)

9/21 (42.9%)

14/30 (46.7%)

5/6 (83.3%)

  

Absent

75/113 (66.8%)

45/56 (80.4%)

29/57 (50.9%)

12 (57.1%)

16/30 (53.3%)

1/6 (16.7%)

 

Diary

  

Present

10/113 (8.8%)

4/56 (7.1%)

6/57 (10.5%)

2/21 (9.5%)

3/30 (10%)

1/6 (16.7%)

  

Absent

102/113 (90.3%)

52/56 (92.9%)

50/57 (87.7%)

18/21 (85.7%)

27/30 (90%)

5/6 (83.3%)

  

Unevaluable

1/113 (0.9%)

0/56 (0%)

1/57 (1.8%)

1/21 (4.8%)

0/30 (0%)

0/6 (0%)

Presence of fecal incontinence

 

STIDAT

  

Present

13/113 (11.5%)

4/56 (7.1%)

9/57 (15.8%)

2/21 (9.5%)

6/30 (20%)

1/6 (16.7%)

  

Absent

100/113 (88.5%)

52/56 (93.9%)

48/57 (84.2%)

19/21 (90.5%)

24/30 (80%)

5/6 (83.3%)

 

Diary

  

Present

12/113 (10.6%)

2/56 (3.6%)

10/57 (17.5%)

2/21 (9.5%)

7/30 (23.3%)

1/6 (16.7%)

  

Absent

100/113 (88.5%)

54/56 (96.4%)

45/57 (79.0%)

17/21 (81.0%)

23/30 (76.7%)

5/6 (83.3%)

  

Unevaluable

1/113 (0.9%)

0/56 (0%)

2/57 (3.5%)

2/21 (9.5%)

0/30 (0%)

0/6 (0%)

Positive use of anti-diarrheals

 

STIDAT

  

Present

7/113 (6.2%)

0/56 (0%)

7/57 (12.3%)

0/21 (0%)

6/30 (20%)

1/6 (16.7%)

  

Absent

106/113 (93.8%)

56/56 (100%)

50/57 (87.7%)

21/21 (100%)

24/30 (80%)

5/6 (83.3%)

 

Diary

  

Present

8/113 (7.1%)

0/56 (0%)

8/57 (14%)

0/21 (0%)

7/30 (23.3%)

1/6 (16.7%)

  

Absent

103/113 (91.2%)

56/56 (100%)

47 (82.5%)

19/21 (90.5%)

23/30 (76.7%)

5/6 (83.3%)

  

Unevaluable

2/113 (1.7%)

0/56 (0%)

2/57 (3.5%)

2/21 (9.5%)

0/30 (0%)

0/6 (0%)

Mean quality of life score (SD)

 

STIDAT

8.1 (2.24)

8.95 (1.70)

7.34 (2.40)

8.12 (1.63)

7.1 (2.46)

4.44 (2.77)

 

EORTC QLQ-C30

6.7 (2.45)

7.25 (2.40)

6.12 (2.39)

6.57 (2.44)

6.20 (2.25)

4.36 (2.50)